Hironori Hayashi

9PUBLICATIONS
42CO-AUTHORS
Medical infection agents (incl. prions)Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsGenetic immunologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
Identification and structure-activity relationship analysis of minimal fusion inhibitors targeting measles virus F protein.

|Jan 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Sep 05, 2024
Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2.

Shin-Ichiro Hattori, Haydar Bulut, Hironori Hayashi

|Feb 09, 2024
Helix-based screening with structure prediction using artificial intelligence has potential for the rapid development of peptide inhibitors targeting class I viral fusion.

Satoshi Suzuki, Mio Kuroda, Keisuke Aoki

|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|Feb 25, 2023
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi

Pageof 2

Frequent Collaborators

4 joint publications

Haydar Bulut

4 joint publications

Kazuya Hasegawa

4 joint publications

Nobutoki Takamune

4 joint publications

Shin-Ichiro Hattori